What Altria does

Altria Group, Inc. (NYSE: MO) is a U.S. tobacco holding company headquartered in Richmond, Virginia, that manufactures and markets combustible and smoke-free tobacco and nicotine products through five operating subsidiaries: Philip Morris USA (cigarettes, including the Marlboro brand with approximately 42% U.S. retail share), U.S. Smokeless Tobacco Company (Copenhagen and other smokeless tobacco), John Middleton (premium cigars), Helix Innovations (on! oral nicotine pouches), and NJOY (e-vapor, acquired 2023). The company is executing a 'Moving Beyond Smoking' transition, targeting $5 billion in smoke-free revenue by 2028 through products like on! PLUS — the first product authorized under the FDA's pilot accelerated review program and launched nationally in March 2026.

Altria distributes products through Altria Group Distribution Company (AGDC), a wholly-owned sales and distribution entity that supports over 212,000 retail stores representing approximately 92% of tobacco industry volume sold in retail stores, with Age Validation Technology deployed in approximately 162,000 of those stores. The business model is a traditional CPG unit-pricing model with significant pricing power — Marlboro commands 42% of the U.S. cigarette market and Altria has implemented approximately 3% price increases, achieving 6.3% net price realization in the smokeable segment in Q1 2026. Smokeable products generated $4.76 billion in Q1 2026 revenue at a 65.1% adjusted operating margin, while oral tobacco (including on!) generated $669 million. End customers are 55 million U.S. adult nicotine consumers 21+, with more than 33% exclusively using smoke-free products.

Altria is a Dividend King with 60 consecutive years of dividend increases, paying $7.1 billion in annual dividends (6.15–6.4% yield) supported by over $8.6 billion in trailing free cash flow, and returning $33.6 billion in dividends plus $7.9 billion in share repurchases from FY 2020 to FY 2024. The current portfolio carries concentrated regulatory and litigation risk, partially offset by FDA authorizations, the withdrawal of the Biden-era menthol ban proposal, and a 2,000+ patent portfolio in harm reduction technologies.

Name

Altria

Legal name

Altria Group, Inc.

Website

https://altria.com

Company type

Public

Founded year

1985

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Altria Group (NYSE: MO) is a Richmond, Virginia-based tobacco holding company that manufactures and markets combustible cigarettes (Marlboro) and smoke-free products (on! nicotine pouches, NJOY e-vapor) through subsidiaries, distributing to over 212,000 U.S. retail stores serving 55 million adult nicotine consumers 21+.

Ownership category

akta.pro rank

Product category

Tobacco Products

NAICS

Tobacco Manufacturing (312230), Tobacco Product and Electronic Cigarette Merchant Wholesalers (42494), Tobacco Product and Electronic Cigarette Merchant Wholesalers (424940), Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers (459991)

SIC

Tobacco Products (2100), Cigarettes (2111), Wholesale-Beer, Wine & Distilled Alcoholic Beverages (5180)

akta.pro primary industry

Cigar & Premium Tobacco Retail (CRANADAB)

akta.pro secondary industries

Dedicated Vape & E-Cigarette Shops (Specialty Retail) (CRANAEAA), Heat-Not-Burn & Alternative Nicotine Device Retail (e.g., IQOS-type) (CRANAEAJ)

Keywords

• Tobacco products
• Cigarette manufacturing
• Smokeless tobacco
• Nicotine pouches
• Smoke-free products

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Smokeable Products: Traditional cigarettes including Marlboro brand, which generates the majority of revenue. Q1 2026 smokeable product revenue was $4.76 billion with 65.1% adjusted operating margin. Domestic cigarette industry volumes declined approximately 5% in Q1 2026.
2. Oral Tobacco Products: Smokeless tobacco products including moist snuff, Copenhagen, and other oral tobacco brands. Q1 2026 oral tobacco revenue was $669 million.
3. Nicotine Pouches (on!): on! nicotine pouch products showing 18% growth with over 46 million cans shipped in Q1 2026. Represents over 58% of total oral tobacco volume. Launched on! PLUS nationwide in March 2026.
4. E-Vapor Products (NJOY): NJOY e-vapor products acquired in 2023. NJOY ACE not expected to return to marketplace in 2026. Subject to FDA regulatory processes.
5. Capital Return to Shareholders: The company returns substantial cash to shareholders through dividends ($7.1 billion annual dividend payout) and share repurchases ($2 billion share repurchase program through December 2026).

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Altria Group, Inc. manufactures and markets tobacco and nicotine products for U.S. adult consumers 21+ through five operating subsidiaries: Philip Morris USA (Marlboro cigarettes), U.S. Smokeless Tobacco Company (Copenhagen and other moist snuff), John Middleton (premium machine-made cigars), Helix Innovations (on! oral nicotine pouches), and NJOY (e-vapor products). The company distributes these products through its Altria Group Distribution Company (AGDC) to over 212,000 retail stores, representing approximately 92% of tobacco industry volume sold in U.S. retail. Altria is transitioning toward smoke-free products under its 'Moving Beyond Smoking' vision.

Product overview

Altria Group is a tobacco and smoke-free products company operating through five subsidiaries: Philip Morris USA (cigarettes, including Marlboro), U.S. Smokeless Tobacco Company (smokeless tobacco), John Middleton (cigars), Helix Innovations (on! oral nicotine pouches), and NJOY (e-vapor products). The company is pursuing a 'Moving Beyond Smoking' vision, transitioning from traditional cigarettes to smoke-free alternatives including nicotine pouches and e-vapor products. The portfolio ranges from combustible products (Marlboro cigarettes) to reduced-risk products (on!, on! PLUS, NJOY) with supporting cessation resources (QuitAssist).

Differentiator

Problem solved

Functional benefit

Products and services

• Marlboro
• on! Nicotine Pouches
• on! PLUS Nicotine Pouches
• NJOY E-Vapor Products E-cigarette and e-vapor products including NJOY ACE, acquired by Altria in 2023 as part of the smoke-free product portfolio expansion.
• John Middleton Cigars
• Smokeless Tobacco Products (Copenhagen and other moist snuff) Smokeless tobacco products including Copenhagen and other moist snuff brands manufactured by U.S. Smokeless Tobacco Company (USSTC), a wholly owned subsidiary of Altria. Q1 2026 oral tobacco revenue was $669 million.

Quantifiable outcome

• Q1 2026 adjusted EPS of $1.32, up 7.3% YoY
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core.

• University of KentuckycoreStrategic or Co-development Partner · 27 April 2026Altria committed $2 million to establish the Endowed Chair in Tobacco Growers Sustainability at the University of Kentucky Martin-Gatton College of Agriculture, Food and Environment. This builds on previous funding for burley and dark-fire tobacco research programs.
• Virginia TechcoreStrategic or Co-development Partner · 27 April 2026Altria committed $2 million endowment to Virginia Tech College of Agriculture and Life Sciences to support tobacco production sustainability research and agricultural education.
• NJOYcoreStrategic or Co-development Partner · 1 May 2023Altria acquired e-cigarette brand NJOY in 2023 as part of its smoke-free product expansion strategy targeting $5 billion in smoke-free revenue by 2028.
• Burger Group (on! Brand)coreStrategic or Co-development Partner · 1 January 2019Altria acquired 80% ownership stake in Burger Group companies commercializing oral tobacco-derived nicotine pouch products under the 'on!' brand for $372 million investment.
• Responsible Business Alliance (RBA)coreStrategic or Co-development PartnerAltria is an affiliate member of RBA, the largest coalition of companies improving corporate social responsibility in global supply chain, committed to promoting social, environmental and ethical standards.
• We Card OrganizationcoreStrategic or Co-development PartnerAltria is a founding sponsor of the We Card organization which provides retailer training and resources to help prevent underage access to tobacco products. We Card has trained hundreds of thousands of retail employees.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Swedish Match: Maker of Zyn nicotine pouches and General snus, now a subsidiary of Philip Morris International; directly comparable to Altria's on!/Helix in the rapidly growing oral nicotine pouch category and a primary share competitor in U.S. pouches.
• ITC Limited: Indian conglomerate with one of the largest cigarette businesses globally (Classic, Gold Flake) and emerging FMCG/diversification strategy; comparable to Altria as a tobacco-led multi-category operator with a long-running combustible core and a stated focus on adjacent smoke-free and non-tobacco growth verticals.
• British American Tobacco: Global tobacco multinational that owns Reynolds American (Newport, Camel) and the Vuse e-vapor brand; directly comparable to Altria as a U.S. market cigarette and smoke-free competitor with overlapping brand portfolios, distribution strategies, and regulatory exposure.
• Vector Group: U.S. holding company for Liggett Group (Liggett, Pyramid, Grand Prix discount cigarettes) and New Valley real estate; directly comparable to Altria as a U.S. cigarette competitor focused on value-priced combustible brands in the same retail and wholesale channels.
• Japan Tobacco International: International tobacco arm of Japan Tobacco Inc. and one of the largest global cigarette manufacturers (Winston, Camel outside the U.S., Mevius); comparable to Altria in scale, combustible dominance, and multi-jurisdiction regulatory exposure.
• Turning Point Brands: U.S. tobacco company in conventional (cigars, make-your-own) and smoke-free (vapor, oral nicotine) categories; directly comparable to Altria as a U.S.-focused tobacco operator competing in the same retail channels and adjacent smoke-free product segments.
• Imperial Brands: UK-listed global tobacco company with significant U.S. and European cigarette presence (Winston, Kool) and a growing next-generation products division; directly comparable to Altria as a multinational tobacco major pursuing reduced-risk product transitions and dividend-driven shareholder returns.
• Philip Morris International: Global tobacco company spun off from Altria in 2008, now the leading international cigarette manufacturer and owner of Swedish Match/Zyn; directly comparable as a combustible-to-smoke-free transitioning tobacco major with similar product portfolio and capital return focus.

Emerging players

• Juul Labs: U.S. e-vapor company once dominant in the pod-based category, now repositioned after regulatory and market share setbacks; comparable to NJOY within Altria's portfolio as a smoke-free nicotine delivery competitor facing FDA PMTA constraints.

Others

• Universal Corporation: Global leaf tobacco merchant and processor supplying major manufacturers including Altria; thematically related as a critical upstream supplier in the tobacco value chain, though not a direct competitor and not a substitute for an investment in branded tobacco.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AltriaNews
• Facebookfacebook.com/AltriaNews
• Instagraminstagram.com/4tobaccorights
• LinkedInlinkedin.com/company/altria

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Altria